BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCL

SIMPLE SUMMARY: T-cell lymphoma is a cancer of the immune system. One specific sub-type of T-cell lymphoma is a malignancy called anaplastic large cell lymphoma (ALCL), which is distinct from the other forms, as in general, it has a better prognosis. Research conducted to understand why ALCL develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Garland, Gavin D., Ducray, Stephen P., Jahangiri, Leila, Pucci, Perla, Amos Burke, G. A., Monahan, Jack, Lai, Raymond, Merkel, Olaf, Schiefer, Ana-Iris, Kenner, Lukas, Bannister, Andrew J., Turner, Suzanne D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750310/
https://www.ncbi.nlm.nih.gov/pubmed/35008316
http://dx.doi.org/10.3390/cancers14010151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750310/
https://www.ncbi.nlm.nih.gov/pubmed/35008316
http://dx.doi.org/10.3390/cancers14010151

Ejemplares similares